Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - OPERATING INCOME
Operating Income APLS - Apellis Pharmaceuticals, Inc.
-517 M
LAST VALUE
1.80%
2 YEAR CAGR
-32.23%
5 YEAR CAGR
-62.49%
10 YEAR CAGR